| scholarly article | Q13442814 |
| P356 | DOI | 10.4088/JCP.V67N1003 |
| P698 | PubMed publication ID | 17107240 |
| P50 | author | Joseph R Calabrese | Q90776679 |
| P2093 | author name string | Mario Saltarelli | |
| Walid Abi-Saab | |||
| Charles L Bowden | |||
| Alan C Swann | |||
| Patricia J Wozniak | |||
| Michelle A Collins | |||
| Depakote ER Mania Study Group | |||
| Leon M Rubenfaer | |||
| P433 | issue | 10 | |
| P921 | main subject | placebo | Q269829 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 1501-1510 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania | |
| P478 | volume | 67 |
| Q35236966 | Acute and long-term treatment of mania. |
| Q37200904 | Bipolar pathophysiology and development of improved treatments |
| Q51912123 | Bupropion for the treatment of methamphetamine dependence. |
| Q34809427 | Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? |
| Q37100104 | Comparison of mania patients suitable for treatment trials versus clinical treatment |
| Q28686902 | Current and emerging therapies for the management of bipolar disorders |
| Q38586755 | Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder |
| Q36836740 | Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder |
| Q33389158 | Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia |
| Q24601815 | Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q53080275 | Factors modifying drug and placebo responses in randomized trials for bipolar mania. |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q43148709 | Is Valproate Depressogenic in Patients Remitting from Acute Mania? Case Series |
| Q33518859 | Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. |
| Q33529314 | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis |
| Q36349023 | Pharmacological treatment of mixed states |
| Q34547500 | Suicidality and divalproex sodium: analysis of controlled studies in multiple indications |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q33664736 | The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders |
| Q37292350 | The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges. |
| Q28744504 | The effectiveness of anticonvulsants in psychiatric disorders |
| Q37076060 | The neuropharmacology of psychosis |
| Q39048607 | Treating mixed mania/hypomania: a review and synthesis of the evidence |
| Q36162402 | Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder |
| Q33364302 | Treatment of bipolar disorder: a systematic review of available data and clinical perspectives |
| Q37973144 | Treatment of mixed bipolar states |
| Q53458719 | What do the suffixes - XR, ER, Chrono, Chronosphere - really mean as it pertains to modified-release antiepileptic drugs? |
| Q34361155 | Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. |
| Q86086565 | [Bipolar disorder: inter-episode symptoms] |
| Q86086575 | [Mixed states] |
Search more.